(S)-1-BOC-3-METHANESULFONYLOXYPYRROLIDINE, 95.0%, 250mg

Ethyl-2-cyanopropionate, 97.0%, 10g

1,2,4-THIADIAZOLE-5-CARBOXYLIC ACID, 3-METHYL-, METHYL ESTER, 95.0%, 100mg

3-(3-Methoxyphenyl)isoxazole-5-carbaldehyde, 95.0%, 1g

tert-Butyl 5-hydroxy-2-aza-bicyclo[2.2.1]heptane-2-carboxylate, 95.0%, 5g

1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) , 100mL, >=99%, for peptide synthesis

2-Methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxylic acid, 95.0%, 5g

6-(Hydroxymethyl)-3-methoxypicolinonitrile, 98%, 10g

3,4-Dinitrobenzoic acid, 98.0%, 5g

Copper hexafluoroacetylacetonate hydrate, 95.0%, 25g

3,4-Dibromofuran, 95.0%, 10g

Oprozomib, 99.71%, 10mg

4,5-Dimethyl-3H-pyrazol-3-one, 5g